BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1956699)

  • 1. Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients.
    Meller-Melloul C; Farnarier C; Dunan S; Faugere B; Franck J; Mary C; Bongrand P; Quilici M; Kaplanski S
    Parasite Immunol; 1991 Sep; 13(5):531-6. PubMed ID: 1956699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of cellular immunity in patients with Mediterranean visceral leishmaniasis].
    Dunan S; Meller C; Kaplanski S; Mary C; Faugère B; Franck J; Toga I; Farnarier C; Quilici M
    Ann Soc Belg Med Trop; 1990 Jun; 70(2):83-97. PubMed ID: 2222009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.
    Tripathi P; Ray S; Sunder S; Dube A; Naik S
    Clin Exp Immunol; 2006 Feb; 143(2):380-8. PubMed ID: 16412064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.
    Garg R; Gupta SK; Tripathi P; Naik S; Sundar S; Dube A
    Clin Exp Immunol; 2005 Apr; 140(1):149-56. PubMed ID: 15762886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
    Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
    Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania infantum-specific IFN-γ production in stimulated blood from cats living in areas where canine leishmaniosis is endemic.
    Priolo V; Martínez-Orellana P; Pennisi MG; Masucci M; Prandi D; Ippolito D; Bruno F; Castelli G; Solano-Gallego L
    Parasit Vectors; 2019 Mar; 12(1):133. PubMed ID: 30909952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
    Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
    Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
    Carvalho EM; Badaró R; Reed SG; Jones TC; Johnson WD
    J Clin Invest; 1985 Dec; 76(6):2066-9. PubMed ID: 3935667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.
    Carvalho EM; Barral A; Pedral-Sampaio D; Barral-Netto M; Badaró R; Rocha H; Johnson WD
    J Infect Dis; 1992 Mar; 165(3):535-40. PubMed ID: 1347057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma interferon production by lymphocytes from children infected with L. chagasi.
    Bacellar O; Barral-Netto M; Badaró R; Carvalho EM
    Braz J Med Biol Res; 1991; 24(8):791-5. PubMed ID: 1797267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
    Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM
    Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and humoral immune responses in a population from the Baringo District, Kenya to Leishmania promastigote lipophosphoglycan.
    Kurtzhals JA; Hey AS; Theander TG; Odera E; Christensen CB; Githure JI; Koech DK; Schaefer KU; Handman E; Kharazmi A
    Am J Trop Med Hyg; 1992 Apr; 46(4):480-8. PubMed ID: 1575296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
    Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of
    Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
    Front Immunol; 2018; 9():843. PubMed ID: 29740446
    [No Abstract]   [Full Text] [Related]  

  • 17. Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice.
    Saljoughian N; Zahedifard F; Doroud D; Doustdari F; Vasei M; Papadopoulou B; Rafati S
    Parasite Immunol; 2013 Dec; 35(12):397-408. PubMed ID: 23710803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an Interferon Gamma Release Assay (IGRA) to test T-cell responsiveness to soluble Leishmania infantum antigen in whole blood of dogs from endemic areas.
    Zribi L; El-Goulli AF; Ben-Abid M; Gharbi M; Ben-Sghaier I; Boufaden I; Aoun K; Bouratbine A
    Vet Parasitol; 2017 Nov; 246():88-92. PubMed ID: 28969786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
    Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
    Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.